149947-15-9

Basic information

• Product Name: 2-BROMO-3-FLUOROBENZALDEHYDE
• Synonyms: 3-BroMo-2-fluorobenzenecarbaldehyde, 95+%;3-Bromo-2-fluorobenzadehyde
• CAS NO: 149947-15-9
• Molecular Formula: C₇H₄BrFO
• Molecular Weight: 203.02
• Product Categories: Benzene series
• Mol File: 149947-15-9.mol
• Article Data: 13

Chemical Properties

• Melting Point: 43-46°C
• Boiling Point: 233.655 °C at 760 mmHg
• Flash Point: >110°(230°F)
• Appearance: Off-white/Powder
• Density: 1.685 g/cm³
• Vapor Pressure: 0.0779mmHg at 25°C
• Refractive Index: 1.584
• Storage Temp.: Room temperature.
• Water Solubility: Slightly soluble in water.
• Sensitive: Light Sensitive
• CAS DataBase Reference: 2-BROMO-3-FLUOROBENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-3-FLUOROBENZALDEHYDE(149947-15-9)
• EPA Substance Registry System: 2-BROMO-3-FLUOROBENZALDEHYDE(149947-15-9)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 149947-15-9(Hazardous Substances Data)

Usage

InChI:InChI=1/C7H4BrFO/c8-7-5(4-10)2-1-3-6(7)9/h1-4H

Upstream product

• 206551-41-9 2-fluoro-3-bromobenzoic acid methyl ester 
• 161957-56-8 3-bromo-2-fluorobenzoic acid 
• 1072-85-1 o-fluorobromobenzene 
• 68-12-2 N,N-dimethyl-formamide 
• 261723-32-4 1-bromo-2-fluoro-3-(hydroxymethyl)benzene 
• 149947-16-0 1-bromo-3-(bromomethyl)-2-fluorobenzene 
• 130286-84-9 N,N-diethyl-3,4-difluorobenzamide 

Downstream Products

• 19075-59-3 7-bromo-1-benzothiophene-2-carboxylic acid 
• 550998-53-3 methyl 7-bromobenzo[b]thiophene-2-carboxylate 
• 869554-82-5 1-bromo-2-fluoro-3-propylbenzene 
• 304876-62-8 C₇H₅BrFNO 
• 1326713-90-9 3-bromo-2-(tert-butylthio)benzaldehyde 
• 1326713-91-0 1-[3-bromo-2-(tert-butylsulfanyl)phenyl]-N-hydroxymethanimine 
• 1698908-91-6 2-[3-(difluoromethyl)-2-fluorophenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 1204333-52-7 1-bromo-3-(difluoromethyl)-2-fluorobenzene 
• 1611443-84-5 2-fluoro-4’-(spiro[3.5]nonan-7-yloxy)-[1,1’-biphenyl]-3-carbaldehyde 
• 1611442-82-0 1-((2-fluoro-4’-(spiro[3.5]nonan-7-yloxy)-[1,1‘-biphenyl]-3-yl)methyl)azetidine-3-carboxylic acid 
• 1445564-37-3 methyl (2R)-2-[(3S)-2-oxo-3-[(6-(pyrrolidin-1-yl)pyridin-3-ylsulphonyl)amino]pyrrolidin-1-yl]-3-(5-fluoro-1-(tritylamino)isoquinolin-6-yl)propanoate 
• 1445564-34-0 methyl (2R)-2-[(3S)-3-amino-2-oxopyrrolidin-1-yl]-3-(5-fluoro-1-(tritylamino)isoquinolin-6-yl)propanoate 
• 1445564-31-7 methyl (2R)-2-[(3S)-3-benzyloxycarbonylamino-2-oxopyrrolidin-1-yl]-3-(5-fluoro-1-(tritylamino)isoquinolin-6-yl)propanoate 
• 1445564-28-2 methyl (2Z)-2-[(3S)-3-benzyloxycarbonylamino-2-oxopyrrolidin-1-yl]-3-(5-fluoro-1-(tritylamino)isoquinolin-6-yl)acrylate 

Relevant articles and documents

Enantioselective Total Synthesis of Beraprost Using Organocatalyst

A convergent and enantioselective total synthesis of the most active isomer of beraprost was achieved in 17 pots. A unique tricyclic core in beraprost was synthesized efficiently by utilizing the asymmetric organocatalyst-mediated formal [3 + 2] cycloaddi

N-(piperidin-4-yl)benzo[b]thiophenecarboxamide derivatives, preparation method therof, and pharmaceutical composition for use in preventing or treating Urotensin-Ⅱ receptor activity related diseases containing the same as an active ingredient

The present invention relates to N-(piperidin-4-yl)benzo[b]thiophenecarboxamide derivatives, a manufacturing method thereof, and a pharmaceutical composition for preventing or treating urotensin-II receptor activity-related diseases comprising the same as an active ingredient. The N-(piperidin-4-yl)benzo[b]thiophenecarboxamide derivatives can be usefully used for preventing or treating urotensin-II receptor activity-related diseases such as congestive heart failure, ischemic heart, myocardial infarction, cardiomegaly, fibrosis cordis, coronary artery disease, arteriosclerosis, hypertension, asthma, renal failure, diabetes, vasculitis, neurodegenerative disease, stroke, pain, depressive disorder, psychosis, cancer, etc., by acting as an antagonist with respect to a urotensin-II receptor.COPYRIGHT KIPO 2016

SULPHONYLAMINOPYRROLIDINONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

The invention relates to new sulphonylaminopyrrolidinone compounds having antithrombotic activity which, in particular, inhibit blood clotting factor IXa and/ or factor Xa, to processes for their preparation and to use thereof as drugs.